Chemoinformaics analysis of 2,6-Dimethyloct-7-en-4-one
| Molecular Weight | 154.253 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 1 |
| Exact Molecular Weight | 154.136 | nRing | 0 |
| Solubility: LogS | -1.287 | nHRing | 0 |
| Solubility: LogP | 1.048 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.586 |
| Synth | 3.352 |
| Natural Product Likeliness | 0.228 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.045 |
| CACO-2 | -4.779 |
| MDCK | 0.0000342 |
| BBB | 0.979 |
| PPB | 0.53391 |
| VDSS | 1.332 |
| FU | 0.659301 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.274 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.841 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.323 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.35 |
| CL | 5.345 |
| T12 | 0.722 |
| hERG | 0.009 |
| Ames | 0.227 |
| ROA | 0.151 |
| SkinSen | 0.1 |
| Carcinogencity | 0.032 |
| EI | 0.035 |
| Respiratory | 0.09 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.94698 |